Trading of Osmetech on Nasdaq Set for June 3 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Osmetech today said that suspension of trading of its shares on AIM in London could occur on Friday, and its shares would begin trading on the Nasdaq next Thursday, if the execution of its Underwriter Agreement is done before tomorrow morning.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.